GCP
GSA Capital Partners Portfolio holdings
AUM
$1.43B
1-Year Return
20.34%
This Quarter Return
-4.34%
1 Year Return
+20.34%
3 Year Return
+63.52%
5 Year Return
+120%
10 Year Return
+237.47%
AUM
$1.17B
AUM Growth
+$167M
(+17%)
Cap. Flow
+$200M
Cap. Flow
% of AUM
17.11%
Top 10 Holdings %
Top 10 Hldgs %
3.75%
Holding
2,064
New
608
Increased
491
Reduced
336
Closed
627
Top Buys
| 1 |
Teck Resources
TECK
|
+$4.06M |
| 2 |
Constellation Brands
STZ
|
+$3.83M |
| 3 |
Revolve Group
RVLV
|
+$3.82M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$3.7M |
| 5 |
NVIDIA
NVDA
|
+$3.67M |
Top Sells
| 1 |
e.l.f. Beauty
ELF
|
+$4.49M |
| 2 |
Copa Holdings
CPA
|
+$3.78M |
| 3 |
Cardlytics
CDLX
|
+$3.54M |
| 4 |
Idexx Laboratories
IDXX
|
+$2.94M |
| 5 |
Sonos
SONO
|
+$2.61M |
Sector Composition
| 1 | Healthcare | 14.25% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Technology | 13.74% |
| 4 | Financials | 11.52% |
| 5 | Industrials | 11.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Fiverr
FVRR
$878M
| $750K | 0.06% |
30,646
-15,087
| -33% | -$369K |
|
|
PTVE
552
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $750K | 0.06% |
92,222
+44,410
| +93% | +$361K |
|
553
Life Time Group Holdings
LTH
$6.46B
| $749K | 0.06% |
49,221
+26,560
| +117% | +$404K |
|
554
Y-mAbs Therapeutics
YMAB
$390M
| $748K | 0.06% |
137,299
+92,765
| +208% | +$505K |
|
555
Old Republic International
ORI
$10.1B
| $747K | 0.06% |
+27,712
| New | +$747K |
|
556
XP
XP
$9.96B
| $747K | 0.06% |
+32,416
| New | +$747K |
|
557
Global Partners
GLP
$1.75B
| $745K | 0.06% |
21,098
-1,867
| -8% | -$65.9K |
|
|
ML
558
DELISTED
MoneyLion Inc.
ML
| $744K | 0.06% |
34,397
-6,858
| -17% | -$148K |
|
559
Chefs' Warehouse
CHEF
$2.69B
| $743K | 0.06% |
+35,070
| New | +$743K |
|
560
On Holding
ONON
$14.1B
| $741K | 0.06% |
26,651
-7,357
| -22% | -$205K |
|
|
DOC
561
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $741K | 0.06% |
+60,800
| New | +$741K |
|
562
iShares ESG Aware MSCI EM ETF
ESGE
$5.34B
| $739K | 0.06% |
24,408
+6,661
| +38% | +$202K |
|
563
Olema Pharmaceuticals
OLMA
$549M
| $738K | 0.06% |
59,773
-42,067
| -41% | -$519K |
|
564
Victory Capital Holdings
VCTR
$4.72B
| $738K | 0.06% |
22,132
+10,852
| +96% | +$362K |
|
565
Puma Biotechnology
PBYI
$227M
| $735K | 0.06% |
279,629
+164,931
| +144% | +$434K |
|
566
Riskified
RSKD
$732M
| $734K | 0.06% |
163,798
+70,238
| +75% | +$315K |
|
567
Ocular Therapeutix
OCUL
$2.22B
| $733K | 0.06% |
233,582
+114,629
| +96% | +$360K |
|
568
Zumiez
ZUMZ
$362M
| $733K | 0.06% |
41,197
-105,997
| -72% | -$1.89M |
|
569
Four Corners Property Trust
FCPT
$2.66B
| $731K | 0.06% |
+32,938
| New | +$731K |
|
570
Origin Bancorp
OBK
$1.1B
| $731K | 0.06% |
+25,321
| New | +$731K |
|
571
Invesco Large Cap Value ETF
PWV
$1.41B
| $731K | 0.06% |
15,612
+1,813
| +13% | +$84.9K |
|
572
Ring Energy
REI
$211M
| $728K | 0.06% |
373,378
+135,635
| +57% | +$264K |
|
573
ResMed
RMD
$40.2B
| $727K | 0.06% |
4,916
+1,619
| +49% | +$239K |
|
|
BCPC
574
Balchem Corporation
BCPC
$5.17B
| $727K | 0.06% |
+5,862
| New | +$727K |
|
|
STKL
575
SunOpta
STKL
$755M
| $725K | 0.06% |
215,026
+107,706
| +100% | +$363K |
|